Yujun Wang

Yujun Wang is an accomplished biotechnology professional with extensive experience in CMC operations and biologics development. Currently serving as Senior Director of CMC Operations at Annexon Biosciences since November 2023, Yujun has held key leadership roles at Codexis, Global Blood Therapeutics, Relypsa, and Nektar Therapeutics, contributing to biologics CMC development, technical operations, and commercial support. Yujun's earlier career includes a research position at the Biological Process Development Facility and a fellowship at OpenBio, showcasing a strong foundation in protein characterization, process development, and product innovation. Yujun holds a Doctor of Philosophy degree in Biotechnology from The University of Alabama in Huntsville.